Drug Profile
RVx 202
Alternative Names: ProfavaxHSV-2; RVx-202; RVx-202 HSV-2Latest Information Update: 27 Jul 2021
Price :
$50
*
At a glance
- Originator Southern Illinois University School of Medicine; University of Kansas
- Developer Rational Vaccines
- Class Attenuated vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes simplex virus type 2 infections
Most Recent Events
- 30 Mar 2021 Preclinical trials in Herpes simplex virus type 2 infections (Prevention) in USA (Intradermal) before July 2021
- 30 Mar 2021 Preclinical trials in Herpes simplex virus type 2 infections (Prevention) in USA (Vaginal) before July 2021
- 30 Mar 2021 Adverse events data from a preclinical studies in Herpes simplex virus type 2 infections released by Rational Vaccines